Advanced Therapy Medicinal Product (ATMP) Manufacturing Market

Global Advanced Therapy Medicinal Product (ATMP) Manufacturing Market Size, Trends & Analysis - Forecasts to 2027 By Therapy Type (Cell Therapy, Gene Therapy, Tissue Engineered Product), By Scale (Pre-commercial/R&D Scale Manufacturing, Commercial Scale Manufacturing), By Workflow (Cell Banking & Processing, Process Development, Fill & Finish Operations, Analytical & Quality Testing), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on April 18 2024 with the latest and most recent market numbers

Global Advanced Therapy Medicinal Product (ATMP) Manufacturing Market Size

The Global Advanced Therapy Medicinal Product (ATMP) Manufacturing Market is projected to grow from USD 9.37 billion in 2022 to USD 22.48 billion at a CAGR value of 12.8% from 2022 to 2027.

ATMPs (advanced therapeutic medical products) are human medicines based on the genetic, cellular, or tissue makeup of human beings. They provide whole new avenues for the treatment of rare sicknesses and critical injuries. Genetic therapy involving the insertion of recombinant genes into the patient to treat cancer, genetic disorders, and other chronic diseases, is also expected to have a positive impact on the growth of the advanced therapeutic medical products market.

As cancer has become one of the leading causes of death worldwide, people are becoming more aware of it and the treatments available. According to the American Cancer Society, approximately 2 million new cancer cases are expected to be reported in the United States by the end of 2022. The number of fatalities arising from cancer and related complications in the United States is anticipated to reach 609,360 in 2022. The growing adoption of gene therapy for cancer treatment is expected to increase the demand for ATMP manufacturing.

The growing adoption of T-cell therapy for treatment among COVID-19 patients in recent years has seen rapid growth in the advanced therapeutic medical products market in the last few years. The Global Institute of Stem Cell Therapy and Research (GIOSTAR) attained FDA clearance in 2021 to provide stem cell therapy for patients suffering from COVID. Through the application of cell therapy for COVID, the market saw a slight increase in demand.

Advanced therapeutic medicinal products can destroy or repair disease-causing cells, providing a curative strategy with unmet medical requirements and the possibility for highly tailored precision medicine. The majority of currently licensed ATMPs target illness indications, however, they are quickly progressing resulting in a growing demand for ATMP manufacturing.

Pharmaceutical and biotechnology companies have been heavily investing in the development of novel advanced therapy medicinal product (ATMP) manufacturing. Recently, Cellipont Bioservices, a leading cell therapy contract manufacturing company has announced plans to expand its ATMP to meet the growing demand from biotechnology and pharmaceutical companies.

As there are no standardized regulatory frameworks specifically created for small-scale production and a lack of specific pharmacopeia monographs for pharmaceutical grade raw materials and raw materials attained from human sources, manufacturing is fragmented, resulting in lower quality, precision, functionality, reproducibility, and stability. These difficulties are frequently exacerbated by a lack of specialist expertise, technical equipment, and trained employees for advanced therapeutic medicinal products compliance. Furthermore, ATMPs are frequently tailored to a small group of patients or are highly personalized. As a result, their manufacturing is difficult to comply with good manufacturing practices or automate to achieve commercialization at a cost-effective level.

global advanced therapy medicinal product (atmp) manufacturing market

COVID-19 Impact on Global Advanced Therapy Medicinal Product (ATMP) Manufacturing Market

The market for advanced therapy medicinal products manufacturing has seen a growth spurt during the pandemic owing to a greater emphasis on pharmaceutical research and development. As companies begin to gain stem cell therapy approvals from the FDA such as Biocardia’s FDA approval for stem cell therapy trials for treating COVID-19, the market for ATMP manufacturing is expected to grow.

Ukraine-Russia War Impact on Pharmaceutical Industry

The conflict between Ukraine and Russia has had severe impacts on the global economy. The advanced therapy medicinal product (ATMP) manufacturing market has surely been affected by disruption in pharmaceutical manufacturing operations in these two countries. The impact on the market has been bolstered by numerous businesses voluntarily stopping activities in Russia. Falling demand for contract manufacturing in the two countries and increasing stress on the resources to meet the demands of the conflict are expected to hamper the growth of the market.

Global Advanced Therapy Medicinal Product (ATMP) Manufacturing Market: By Therapy Type

The gene therapy segment is expected to be the largest advanced therapy medicinal product (ATMP) manufacturing market segment based on the therapy type. The large number of FDA-approved gene therapy-based treatment options that are available for treating various types of cancer and chronic illnesses has led to the dominance of the gene therapy segment. The heavy investment in the development of novel targeted treatments for blood cancer has also played a crucial role in the development of this segment.

The cell therapy segment is expected to be the fastest-growing segment in the market. The cell therapy segment already has seen an increase in the availability of cell therapy for treating COVID-19 and other infectious diseases, and the expected increase in FDA approvals for new cell therapies is expected to further expand the market segment.

Global Advanced Therapy Medicinal Product (ATMP) Manufacturing Market: By Scale

The pre-commercial/R&D scale manufacturing segment is expected to be the largest advanced therapy medicinal product (ATMP) manufacturing market segment based on the scale. The growing number of cell therapy and gene therapy-based pharmaceuticals that are being developed by major pharmaceutical companies has been a major driver of the segment. The problem with the scalability of ATMP manufacturing has also led to the domination of the pre-commercial/R&D scale manufacturing segment.

The commercial-scale manufacturing segment is expected to be the fastest-growing segment in the market. The growing advancements in technology and rising approval rate for advanced therapy medicinal products are expected to be the major driver of the commercial-scale manufacturing segment.

Global Advanced Therapy Medicinal Product (ATMP) Manufacturing Market: By Workflow

The cell banking & processing segment is expected to be the largest advanced therapy medicinal product (ATMP) manufacturing market segment based on the workflow. The growing demand for cell therapy and increasing demand for raw materials in cell therapy has led to the large demand for the cell banking & processing segment.

The process development segment is expected to be the fastest-growing segment in the market. The growing demand for cost, revenue, and materials analysis among pharmaceutical manufacturing companies specializing in advanced therapy medicinal products is expected to increase the demand for the process development segment.

asia pacific advanced therapy medicinal product (atmp) manufacturing market

Global Advanced Therapy Medicinal Product (ATMP) Manufacturing Market: By Region

North America (the United States, Canada, and Mexico) will dominate the Advanced Therapy Medicinal Product (ATMP) Manufacturing market from 2022 to 2027. Growing investment in tissue therapy, cell therapy, and gene therapy has been a major driver of the market in the North American region.

The United States is expected to have the lion's share in the North American advanced therapy medicinal product (ATMP) manufacturing market. The growing number of FDA approvals for gene therapy and stem cell therapy treatment procedures are expected to increase the demand for advanced therapy medicinal products.

However, the Asia-Pacific region is expected to be the fastest-growing region in the advanced therapy medicinal product (ATMP) manufacturing market during the forecast period. The growing pharmaceutical manufacturing industry in the region combined with the rising investment in cell therapy in the region has been a major contributor to the growth of the market in the APAC region

China is expected to hold the largest share in the Asia Pacific advanced therapy medicinal product (ATMP) manufacturing market. The growing investment in the development of novel treatment procedures and pharmaceuticals in the country is expected to increase the demand for ATMP manufacturing in China.

Global Advanced Therapy Medicinal Product (ATMP) Manufacturing Market Share and Competitor Analysis

Thermofisher Scientific, Inc., Merck KGaA, Lonza, Catalent Inc., Takara Bio Inc., F.Hoffmann-La Roche Ltd, Wuxi Advanced Therapies, Novartis AG, Miltenyi Biotec, bluebird bio, Inc., Boehringer Ingelheim International GMBH, Gilead Sciences, Inc., ElevateBio, LLC, VGXI, Inc., Sangamo Therapeutics, Inc., Oxford Biomedica, Aldevron, LLC, Novasep, Yposkesi, REGENXBIO Inc., Orchard Therapeutics, BioMarin Pharmaceutical Inc., Avantor, Inc., Astellas Pharma Inc., and Kriya Therapeutics, among others, are the some of the key players in the advanced therapy medicinal product (ATMP) manufacturing market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Research Methodology

1.1 Research Assumptions

1.2 Research Methodology

1.2.1 Estimates and Forecast Timeline

1.3 Information Procurement

1.3.1 Purchased Database

1.3.2 GME’s Internal Database

1.3.3 Primary Research

1.3.4 Secondary Sources & Third-Party Perspectives

1.3.4.1 Company Information Sources: Annual Reports, Investor Presentation, Press Release, SEC Filling, Company Blogs & Website

1.3.4.2 Secondary Data Sources: World Health Organization, USFDA, IFPMA, American Association of Pharmaceutical Scientists, American Society of Health Systems, and FAPA, among others

1.4 Information or Data Analysis

1.4.1 Data Analysis Models

1.5 Market Formulation & Data Visualization

1.6 Data Validation & Publishing

1.7 Market Model

1.7.1 Model Details

1.7.1.1 Top-Down Approach

1.7.1.2 Bottom-Up Approach

1.8 Market Segmentation & Scope

1.9 Market Definition

Chapter 2 Executive Summary

2.1. Global Market Outlook

2.2 Therapy Type Outlook

2.3 Scale Outlook

2.4 Workflow Outlook

2.5 Regional Outlook

Chapter 3 Global Clinical PCR Market Trend Analysis

3.1. Market Introduction

3.2 Penetration & Growth Prospect Mapping

3.3 Impact of COVID-19 on the Clinical PCR Market

3.4 Metric Data on Cash Transactions

3.5 Market Driver Analysis

3.5.1 Market Driver Analysis

3.5.2 Market Restraint Analysis

3.5.3 Industry Challenges

3.5.4 Industry Opportunities

3.6 Porter’s Five Analysis

3.6.1 Supplier Power

3.6.2 Buyer Power

3.6.3 Substitution Threat

3.6.4 Threat from New Entrant

3.7 Market Entry Strategies

Chapter 4 Clinical PCR Market: Therapy Type Trend Analysis

4.1 Therapy Type: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027

4.2 Cell Therapy

4.2.1 Market Estimates & Forecast Analysis of Cell Therapy Segment, By Region, 2019-2027 (USD Billion)

4.3 Gene Therapy

4.3.1 Market Estimates & Forecast Analysis of Gene Therapy Segment, By Region, 2019-2027 (USD Billion)

4.4 Tissue Engineered Product

4.4.1 Market Estimates & Forecast Analysis of Tissue Engineered Product Segment, By Region, 2019-2027 (USD Billion)

Chapter 5 Clinical PCR Market: Scale Trend Analysis

5.1 Scale: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027

5.2 Pre-commercial/R&D Scale Manufacturing

5.2.1 Market Estimates & Forecast Analysis of Pre-commercial/R&D Scale Manufacturing Segment, By Region, 2019-2027 (USD Billion)

5.3 Commercial Scale Manufacturing

5.3.1 Market Estimates & Forecast Analysis of Commercial Scale Manufacturing Segment, By Region, 2019-2027 (USD Billion)

Chapter 6 Clinical PCR Market: Workflow Trend Analysis

6.1 Workflow: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027

6.2 Cell Banking & Processing

6.2.1 Market Estimates & Forecast Analysis of Cell Banking & Processing Workflow Segment, By Region, 2019-2027 (USD Billion)

6.3 Process Development

6.3.1 Market Estimates & Forecast Analysis of Process Development Workflow Segment, By Region, 2019-2027 (USD Billion)

6.4 Fill & Finish Operations

6.4.1 Market Estimates & Forecast Analysis of Others Workflow Segment, By Region, 2019-2027 (USD Billion)

6.5 Analytical and Quality Testing

6.5.1 Market Estimates & Forecast Analysis of Analytical and Quality Testing Workflow Segment, By Region, 2019-2027 (USD Billion)

6.6 Others

6.6.1 Market Estimates & Forecast Analysis of Others Workflow Segment, By Region, 2019-2027 (USD Billion)

Chapter 7 Clinical PCR Market, By Region

7.1 Regional Outlook

7.2 North America

7.2.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.2.2 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.2.3 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.2.4 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.2.5 U.S.

7.2.5.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.2.5.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.2.5.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.2.6 Canada

7.2.6.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.2.6.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.2.6.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.5.7 Mexico

7.5.5.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.5.5.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.5.5.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.3 Europe

7.3.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.3.2 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.3.3 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.3.4 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.3.5 Germany

7.3.5.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.3.5.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.3.5.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.3.6 UK

7.3.6.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.3.6.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.3.6.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.3.7 France

7.3.7.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.3.7.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.3.7.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.3.8 Russia

7.3.8.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.3.8.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.3.8.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.3.9 Italy

7.3.9.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.3.9.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.3.9.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.3.10 Spain

7.3.10.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.3.10.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.3.10.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.3.11 Rest of Europe

7.3.11.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.3.11.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.3.11.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.4 Asia Pacific

7.4.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.4.2 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.4.3 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.4.4 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.4.5 China

7.4.5.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.4.5.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.4.5.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.4.6 India

7.4.6.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.4.6.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.4.6.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.4.7 Japan

7.4.7.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.4.7.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.4.7.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.4.8 Australia

7.4.8.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.4.8.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.4.8.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.4.9 South Korea

7.4.9.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.4.9.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.4.9.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.3.10 Rest of Asia Pacific

7.3.10.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.3.10.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.3.10.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.5 Central & South America

7.5.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.5.2 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.5.3 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.5.4 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.5.5 Brazil

7.5.5.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.5.5.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.5.5.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.5.6 Rest of Central & South America

7.5.6.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.5.6.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.5.6.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.6 Middle East & Africa

7.6.1 Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.6.2 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.6.3 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.6.4 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.6.5 Saudi Arabia

7.6.5.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.6.5.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.6.5.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.6.6 United Arab Emirates

7.6.6.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.6.6.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.6.6.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.6.7 South Africa

7.6.7.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.6.7.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.6.7.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

7.5.8 Rest of Middle East & Africa

7.5.8.1 Market Estimates & Forecast Analysis, By Therapy Type, 2019-2027 (USD Billion)

7.5.8.2 Market Estimates & Forecast Analysis, By Scale, 2019-2027 (USD Billion)

7.5.8.3 Market Estimates & Forecast Analysis, By Workflow, 2019-2027 (USD Billion)

Chapter 8 Competitive Analysis

8.1 Key Global Players, Recent Developments & their Impact on the Industry

8.2 Four Quadrant Competitor Positioning Matrix

8.2.1 Key Innovators

8.2.2 Market Leaders

8.2.3 Emerging Players

8.2.4 Market Challengers

8.3 Vendor Landscape Analysis

8.4 End-User Landscape Analysis

8.5 Company Market Share Analysis, 2021

Chapter 9 Company Profile Analysis

9.1 Thermo Fisher Scientific, Inc.

9.1.1 Company Overview

9.1.2 Financial Analysis

9.1.3 Strategic Initiatives

9.1.4 Product Benchmarking

9.2 Merck KGaA

9.2.1 Company Overview

9.2.2 Financial Analysis

9.2.3 Strategic Initiatives

9.2.4 Product Benchmarking

9.3 F. Hoffmann-La Roche Ltd.

9.3.1 Company Overview

9.3.2 Financial Analysis

9.3.3 Strategic Initiatives

9.3.4 Product Benchmarking

9.4 Lonza

9.4.1 Company Overview

9.4.2 Financial Analysis

9.4.3 Strategic Initiatives

9.4.4 Product Benchmarking

9.5 Catalent Inc.

9.5.1 Company Overview

9.5.2 Financial Analysis

9.5.3 Strategic Initiatives

9.5.4 Product Benchmarking

9.6 Takara Bio Inc.

9.6.1 Company Overview

9.6.2 Financial Analysis

9.6.3 Strategic Initiatives

9.6.4 Product Benchmarking

9.7 Wuxi Advanced Therapies

9.7.1 Company Overview

9.7.2 Financial Analysis

9.7.3 Strategic Initiatives

9.7.4 Product Benchmarking

9.8 Novartis AG

9.8.1 Company Overview

9.8.2 Financial Analysis

9.8.3 Strategic Initiatives

9.8.4 Product Benchmarking

9.9 Miltenyi Biotec

9.9.1 Company Overview

9.9.2 Financial Analysis

9.9.3 Strategic Initiatives

9.9.4 Product Benchmarking

9.10 Bluebird bio, Inc.

9.10.1 Company Overview

9.10.2 Financial Analysis

9.10.3 Strategic Initiatives

9.10.4 Product Benchmarking

9.11 Other Companies

9.11.1 Company Overview

9.11.2 Financial Analysis

9.11.3 Strategic Initiatives

9.11.4 Product Benchmarking

List of Tables

1 Technological Advancements In Clinical PCR Market

2 Global Clinical PCR Market: Key Market Drivers

3 Global Clinical PCR Market: Key Market Challenges

4 Global Clinical PCR Market: Key Market Opportunities

5 Global Clinical PCR Market: Key Market Restraints

6 Global Clinical PCR Market Estimates & Forecast Analysis, 2019-2027 (USD Billion)

7 Global Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

8 Cell Therapy: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

9 Gene Therapy: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

10 Tissue Engineered Product: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

11 Global Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

12 Pre-commercial/R&D Scale Manufacturing: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

13 Commercial Scale Manufacturing: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

14 Global Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

15 Cell Banking & Processing: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

16 Process Development: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

17 Fill & Finish Operations: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

18 Analytical and Quality Testing: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

19 Others: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

20 Regional Analysis: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

21 North America: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

22 North America: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

23 North America: Clinical PCR Market, By Workflow , 2019-2027 (USD Billion)

24 North America: Clinical PCR Market, By Country, 2019-2027 (USD Billion)

25 U.S: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

26 U.S: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

27 U.S: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

28 Canada: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

29 Canada: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

30 Canada: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

31 Mexico: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

32 Mexico: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

33 Mexico: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

34 Europe: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

35 Europe: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

36 Europe: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

37 Europe: Clinical PCR Market, By Country, 2019-2027 (USD Billion)

38 Germany: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

39 Germany: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

40 Germany: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

41 UK: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

42 UK: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

43 UK: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

44 France: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

45 France: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

46 France: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

47 Italy: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

48 Italy: Clinical PCR Market, By T Scale Ype, 2019-2027 (USD Billion)

49 Italy: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

50 Spain: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

51 Spain: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

52 Spain: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

53 Rest Of Europe: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

54 Rest Of Europe: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

55 Rest Of Europe: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

56 Asia Pacific: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

57 Asia Pacific: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

58 Asia Pacific: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

59 Asia Pacific: Clinical PCR Market, By Country, 2019-2027 (USD Billion)

60 China: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

61 China: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

62 China: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

63 India: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

64 India: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

65 India: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

66 Japan: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

67 Japan: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

68 Japan: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

69 South Korea: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

70 South Korea: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

71 South Korea: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

72 Middle East & Africa: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

73 Middle East & Africa: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

74 Middle East & Africa: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

75 Middle East & Africa: Clinical PCR Market, By Country, 2019-2027 (USD Billion)

76 Saudi Arabia: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

77 Saudi Arabia: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

78 Saudi Arabia: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

79 UAE: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

80 UAE: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

81 UAE: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

82 Central & South America: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

83 Central & South America: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

84 Central & South America: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

85 Central & South America: Clinical PCR Market, By Country, 2019-2027 (USD Billion)

86 Brazil: Clinical PCR Market, By Therapy Type, 2019-2027 (USD Billion)

87 Brazil: Clinical PCR Market, By Scale, 2019-2027 (USD Billion)

88 Brazil: Clinical PCR Market, By Workflow, 2019-2027 (USD Billion)

89 Thermo Fisher Scientific, Inc.: Products Offered

90 Merck KGaA: Products Offered

91 F. Hoffmann-La Roche Ltd.: Products Offered

92 Lonza: Products Offered

93 Catalent Inc.: Products Offered

94 Takara Bio Inc.: Products Offered

95 Wuxi Advanced Therapies: Products Offered

96 Novartis AG: Products Offered

97 Miltenyi Biotec: Products Offered

98 Bluebird bio, Inc.: Products Offered

99 Other Companies: Products Offered

List of Figures

1. Global Clinical PCR Market Segmentation & Research Scope

2. Primary Research Partners and Local Informers

3. Primary Research Process

4. Primary Research Approaches

5. Primary Research Responses

6. Global Clinical PCR Market: Penetration & Growth Prospect Mapping

7. Global Clinical PCR Market: Value Chain Analysis

8. Global Clinical PCR Market Drivers

9. Global Clinical PCR Market Restraints

10. Global Clinical PCR Market Opportunities

11. Global Clinical PCR Market Challenges

12. Key Clinical PCR Market Manufacturer Analysis

13. Global Clinical PCR Market: Porter’s Five Forces Analysis

14. PESTLE Analysis & Impact Analysis

15. Thermo Fisher Scientific, Inc.: Company Snapshot

16. Thermo Fisher Scientific, Inc.: Swot Analysis

17. Merck KGaA: Company Snapshot

18. Merck KGaA: Swot Analysis

19. F. Hoffmann-La Roche Ltd.: Company Snapshot

20. F. Hoffmann-La Roche Ltd.: Swot Analysis

21. Lonza: Company Snapshot

22. Lonza: Swot Analysis

23. Catalent Inc.: Company Snapshot

24. Catalent Inc.: Swot Analysis

25. Takara Bio Inc.: Company Snapshot

26. Takara Bio Inc.: Swot Analysis

27. Wuxi Advanced Therapies: Company Snapshot

28. Wuxi Advanced Therapies: Swot Analysis

29. Novartis AG: Company Snapshot

30. Novartis AG: Swot Analysis

31. Miltenyi Biotec: Company Snapshot

32. Miltenyi Biotec: Swot Analysis

33. Bluebird bio, Inc.: Company Snapshot

34. Bluebird bio, Inc.: Swot Analysis

35. Other Companies: Company Snapshot

36. Other Companies: Swot Analysis

The Global Advanced Therapy Medicinal Product (ATMP) Manufacturing Market has been studied from the year 2019 till 2027. However, the CAGR provided in the report is from the year 2022 to 2027. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Advanced Therapy Medicinal Product (ATMP) Manufacturing Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global advanced therapy medicinal product (ATMP) manufacturing market?

The global advanced therapy medicinal product (ATMP) manufacturing market is projected to grow from USD 9.37 billion in 2022 to USD 22.48 billion at a CAGR value of 12.8% from 2022 to 2027.

Who are the major vendors in the advanced therapy medicinal product (ATMP) manufacturing market?

What is the Covid-19 impact on future advanced therapy medicinal product (ATMP) manufacturing providers?

What are the major drivers in the advanced therapy medicinal product (ATMP) manufacturing market?

The growing investment in the development of novel gene therapy-based cancer treatments, the growing availability of cell therapy in the market, the growing investment in ATMP manufacturing, and technological advancements in commercial ATMP manufacturing are the major drivers of the advanced therapy medicinal product (ATMP) manufacturing market.

What is the impact of the Ukraine-Russia war on the pharmaceutical sector?